Foundation Takes No Stand on Treatments
The Forward’s August 4 article, “Gaucher Disease Patients Get New Hope From Drug,” does not in any way represent the views or opinions of the National Gaucher Foundation. They are, in fact, only those of Cyndi Frank, a patient. Therefore the NGF should not have appeared in that article in any manner.
The NGF does not advocate for any one treatment or pharmaceutical company, as each patient’s needs are different. Only a patient and his or her physician can make an intelligent decision about the proper treatment.
The NGF, a not-for-profit organization, is an unbiased voice for the entire Gaucher community. Our goal is to always present objective and educational information. We worry that the article’s inference that the oral treatment — which has yet to be FDA-approved — is superior to the life-saving drugs that have been and are currently on the market, is misleading. We feel that the article suggests NGF’s endorsement of this treatment. We would like to set the record straight and say that this is not true — it is imperative that we remain unbiased in order to serve the community in the best possible way.
Rhonda P. Buyers
CEO
National Gaucher Foundation
Tucker, Ga.
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

